In clinical trials, participants using Zepbound achieved an average weight loss of approximately 20.2% over 72 weeks, while those on Wegovy experienced about a 13.7% reduction
Sergey Terushkin, MD, FACS Florida Surgery & Weight Loss Center Medically Reviewed By: Dr
Author contributions: Conceptualization: M.K., J.P.T., X.L.-H., R.K., D.L., and B.W
Preamble Health is a medical practice in Scottsdale, Arizona
Back Mentlein, R, Galllwitz, B, Schmidt, WE (June 1993) 'Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36) amide, peptide histidine methionine and is responsible for their degradation in human serum', European Journal of Biochemistry , 214, 829-35
FDA approves first oral GLP-1 treatment for type 2 diabetes B